ANTIVIRAL ACTIVITY AND EMBRYONIC TOXICITY OF MOXIDECTIN AGAINST INFLUENZA VIRUS H9

Author(s)

Hameed R1, Tahir M1, Azeem S1, Anjum MS2, Iqbal MZ3, Tanveer MZ1
1University of Veterinary and Animal Sciences, Lahore, Pakistan., Lahore, Pakistan, 2PMAS- Arid Agriculture University, Rawalpindi, Pakistan, Rawalpindi, Pakistan, 3AIMST University,, Bedong, Kedah Darul Aman, Malaysia, Malaysia

Cytotoxic and antiviral potential of Moxidectin against influenza virus H9 was evaluated. The cytotoxicity of moxidectin was evaluated on primary fibroblast cell line through MTT assay. Antiviral activity in vitro and in vivo was tested on 9-days old chick embryo. Cytotoxicity and antiviral activity of Moxidectin is high at first two conc. 200µg/ml and 100µg/ml while safe at lower conc. 50, 25, 12.5 and 6.25µg/ml. It was concluded that concentrations of moxidectin 200 and 100µg/ml were cytotoxic and lower concentrations were safe. Moxidectin showed strong antiviral activity against influenza virus H9 at all concentrations but found to be safer on concentrations like 50, 25, 12.5 and 6.25µg/ml.

Conference/Value in Health Info

2016-09, ISPOR Asia Pacific 2016, Singapore

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PRM47

Topic

Methodological & Statistical Research

Topic Subcategory

Confounding, Selection Bias Correction, Causal Inference

Disease

Infectious Disease (non-vaccine)

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×